Danaher Corporation (DHR) support and resistance · P/E 39, rev $24.57B
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
This page maps Danaher Corporation (DHR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DHR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DHR quote page for the session range and the stock page for the full model.
Not investment advice.